HAE vs JLL · P/E 35, rev $1.33B vs P/E 23, rev $13.31B
Haemonetics Corporation (HAE) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the HAE and JLL stock pages for the full models.
Not investment advice.